Xeris Biopharma (XERS) News Today $8.20 -0.08 (-0.97%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$8.28 +0.08 (+0.91%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XERS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Brokerages Set Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Price Target at $7.083 hours ago | americanbankingnews.comWeiss Ratings Reiterates Sell (D-) Rating for Xeris Biopharma (NASDAQ:XERS)October 8 at 2:11 PM | marketbeat.comXeris Biopharma (NASDAQ:XERS) Stock Price Down 4% - Here's What HappenedOctober 8 at 1:34 PM | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from AnalystsOctober 6 at 2:21 AM | marketbeat.comXeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 3, 2025 | businesswire.comXeris Biopharma (NASDAQ:XERS) Hits New 12-Month High - Time to Buy?October 2, 2025 | marketbeat.comStrs Ohio Buys New Holdings in Xeris Biopharma Holdings, Inc. $XERSSeptember 24, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Stock Price Down 7.2% - Should You Sell?September 20, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Sets New 52-Week High - Should You Buy?September 19, 2025 | marketbeat.comAQR Capital Management LLC Has $5.20 Million Stake in Xeris Biopharma Holdings, Inc. $XERSSeptember 15, 2025 | marketbeat.comInsider Selling: Xeris Biopharma (NASDAQ:XERS) Director Sells 15,500 Shares of StockSeptember 14, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires Shares of 255,560 Xeris Biopharma Holdings, Inc. $XERSSeptember 14, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Director Sells $119,660.00 in StockSeptember 13, 2025 | insidertrades.comFred Alger Management LLC Buys New Stake in Xeris Biopharma Holdings, Inc. $XERSSeptember 13, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Consensus Recommendation of "Moderate Buy" by AnalystsSeptember 12, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Short Interest Down 26.7% in AugustSeptember 9, 2025 | marketbeat.comParkman Healthcare Partners LLC Has $9.78 Million Stock Position in Xeris Biopharma Holdings, Inc. $XERSSeptember 8, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Downgraded by Wall Street Zen to BuySeptember 8, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes Position in Xeris Biopharma Holdings, Inc. $XERSSeptember 7, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Stock Holdings Raised by Graham Capital Management L.P.September 7, 2025 | marketbeat.comBosun Asset Management LLC Acquires New Holdings in Xeris Biopharma Holdings, Inc. $XERSSeptember 6, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Reaches New 12-Month High - Time to Buy?September 5, 2025 | marketbeat.comXeris In Recorlev-Fuelled Growth: Why I Choose To BuySeptember 5, 2025 | seekingalpha.comPDT Partners LLC Buys New Shares in Xeris Biopharma Holdings, Inc. $XERSSeptember 5, 2025 | marketbeat.comIeq Capital LLC Boosts Holdings in Xeris Biopharma Holdings, Inc. $XERSSeptember 5, 2025 | marketbeat.comQuarry LP Makes New $388,000 Investment in Xeris Biopharma Holdings, Inc. $XERSSeptember 3, 2025 | marketbeat.comAlpine Global Management LLC Has $549,000 Stock Position in Xeris Biopharma Holdings, Inc. $XERSSeptember 2, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Shares Purchased by Driehaus Capital Management LLCSeptember 2, 2025 | marketbeat.comWellington Management Group LLP Has $2.15 Million Stake in Xeris Biopharma Holdings, Inc. $XERSSeptember 2, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 113,713 Shares of Xeris Biopharma Holdings, Inc. $XERSSeptember 1, 2025 | marketbeat.comJeffrey Sherman Sells 42,232 Shares of Xeris Biopharma (NASDAQ:XERS) StockAugust 30, 2025 | insidertrades.comQuantbot Technologies LP Purchases Shares of 54,107 Xeris Biopharma Holdings, Inc. $XERSAugust 30, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Stake Increased by Invesco Ltd.August 30, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 RevenueAugust 29, 2025 | uk.finance.yahoo.comWalleye Capital LLC Invests $3.80 Million in Xeris Biopharma Holdings, Inc. $XERSAugust 29, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Holdings Raised by Jump Financial LLCAugust 29, 2025 | marketbeat.comVanguard Group Inc. Purchases 210,581 Shares of Xeris Biopharma Holdings, Inc. $XERSAugust 28, 2025 | marketbeat.comStonepine Capital Management LLC Sells 80,052 Shares of Xeris Biopharma Holdings, Inc. $XERSAugust 26, 2025 | marketbeat.comXeris Announces Orange Book Listing of U.S. Patent for Recorlev®August 25, 2025 | finance.yahoo.comXeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, Leerink Partners Analyst SaysAugust 24, 2025 | marketbeat.comFY2025 EPS Estimates for Xeris Biopharma Boosted by AnalystAugust 24, 2025 | marketbeat.comNuveen LLC Buys New Shares in Xeris Biopharma Holdings, Inc. $XERSAugust 24, 2025 | marketbeat.comCetera Investment Advisers Buys New Shares in Xeris Biopharma Holdings, Inc. $XERSAugust 24, 2025 | marketbeat.comQ3 EPS Estimates for Xeris Biopharma Decreased by AnalystAugust 23, 2025 | marketbeat.comVoss Capital LP Makes New Investment in Xeris Biopharma Holdings, Inc. $XERSAugust 21, 2025 | marketbeat.comDeutsche Bank AG Grows Position in Xeris Biopharma Holdings, Inc. $XERSAugust 19, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Rating of "Moderate Buy" by AnalystsAugust 18, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director John Johnson Sells 107,500 SharesAugust 17, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Sets New 52-Week High - Here's WhyAugust 17, 2025 | marketbeat.comJohn Johnson Sells 107,500 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) StockAugust 16, 2025 | insidertrades.com Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XERS Media Mentions By Week XERS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XERS News Sentiment▼0.570.63▲Average Medical News Sentiment XERS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XERS Articles This Week▼64▲XERS Articles Average Week Get the Latest News and Ratings for XERS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Xeris Biopharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MRUS News KRYS News PTCT News MENS News ARWR News ACLX News PCVX News CRNX News PTGX News KYMR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XERS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xeris Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
